OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totaling 113,555 shares, a decline of 87.7% from the September 15th total of 922,431 shares. Based on an average daily volume of 94,253 shares, the short-interest ratio is currently 1.2 days. Approximately 3.8% of the company’s stock are short sold.
Analysts Set New Price Targets
Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, OneMedNet presently has an average rating of “Sell”.
View Our Latest Research Report on ONMD
Insider Buying and Selling at OneMedNet
OneMedNet Price Performance
Shares of OneMedNet stock traded down $0.52 during midday trading on Friday, hitting $4.30. The company had a trading volume of 24,653 shares, compared to its average volume of 69,105. OneMedNet has a 1-year low of $4.30 and a 1-year high of $42.20. The business’s 50 day simple moving average is $6.24 and its two-hundred day simple moving average is $7.32. The stock has a market cap of $25.50 million, a PE ratio of -2.69 and a beta of 1.14.
About OneMedNet
OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.
The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.
See Also
- Five stocks we like better than OneMedNet
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
- MarketBeat Week in Review – 10/05 – 10/09
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
